Therapeutic targets of the TNF superfamily
By: edited by Iqbal S. Grewal.
Contributors: Grewal, Iqbal S.
Series: Advances in experimental medicine and biology -- v. 647
Publisher: Springer Science+Business Media; Landes Bioscience
Published: 2009
Place of publication: New York; Austin, Tex
Language: eng
ISBN-13: 9780387895192
Subjects: Tumor necrosis factor.; Tumor necrosis factor -- Agonists -- Therapeutic use.; Tumor Necrosis Factors -- therapeutic use.; Autoimmune Diseases -- drug therapy.; Inflammation -- drug therapy.; Neoplasms -- drug therapy.; Receptors, Tumor Necrosis Factor -- therapeutic use.
Notes: Includes bibliographical references and index.
Table of contents: value: Overview of TNF superfamily : a chest full of potential therapeutic targets / Iqbal S. Grewal; value: Therapeutic interventions targeting CD40l (CD154) and CD40 : the opportunities and challenges / Che-Leung Law and Iqbal S. Grewal; value: Targeting TNF for treatment of cancer and autoimmunity / Gautam Sethi ... [et al.]; value: Targeting of BAFF and APRIL for autoimmunity and oncology / Maureen C. Ryan and Iqbal S. Grewal; value: The role of FASL and FAS in health and disease / Martin Ehrenschwender and Harald Wajant; value: OX40 (CD134) and OX401 / Michael J. Gough and Andrew D. Weinberg; value: Targeting CD70 for human therapeutic use / Tamar Boursalian ... [et al.]; value: 4-1BB as a therapeutic target for human disease / Seung-Woo Lee and Michael Croft; value: Rank(l) as a key target for controlling bone loss / Andreas Leibbrandt and Josef M. Penninger; value: Targeting the light-HVEM pathway / Carl F. Ware; value: GITR : a modulator of immune response and inflammation / Giuseppe Nocentini and Carlo Riccardi; value: Targeting CD30/CD30l in oncology and autoimmune and inflammatory diseases / Ezogelin Oflazoglu, Iqbal S. Grewal, and Hans Peter Gerber; value: Tumor necrosis factor receptor superfamily member 21 : TNFR-related death receptor-6, DR6 / Robert Benschop, Tao Wei, and Songqing Na; value: TRAIL and other TRAIL receptor agonists as novel cancer therapeutics / Christina Falschlehner ... [et al.]; value: Therapeutic potential of VEGI/TL1A; value: In autoimmunity and cancer / Gautam Sethi, Bokyung Sung, and Bharat B. Aggarwal.